In the two years since the installation of the Vaccine Branch Astrios-EQ (installed mid-2014, in conjunction with a CRADA that we initiated with Beckman-Coulter in 2013), we developed nanoFACS protocols for fluorescence detection and calibration, for counting, and for high-throughput sorting, to sort EV subsets from plasma and other biofluids by nanoFACS. Using multiple distinct vesicle populations, we find that nanoFACS sorting is uniquely able to produce high fidelity EV subsets (95-97% pure), with functional biological cargo (RNA and protein). During the past 9-10 months, our focus has been exclusively on application of this method for clinically important studies, for the study of cancer disease burden, metastatic potential, and responses to treatment. Our NanoFACS approach that we developed as part of this ACI program is the only method currently able to analyze and preparatively sort functional EVs based on single EV characteristics, rather than bulk attributes. Furthermore, we have devised a new class of labels (Molecular NanoTags) that can be used with nanoFACS, not only to improve the detection of EV epitopes, but also to enable single molecule counting by flow cytometry. The specialized instrumentation and expertise assembled for this nanoFACS program does not exist anywhere else in the world, is a distinctive asset for NCI. We now have a unique opportunity to leverage this nanoFACS program in the Clinical Center to demonstrate the potential impact of this approach for oncology, immunology, and personalized medicine. Toward the goal of utilizing nanoFACS in the study of tumor-derived EVs as a liquid biopsy, we have tested and confirmed nanoFACS resolution of cancer and cancer stem-cell markers: PSMA, CD147, CD44, and CD26. During the past 6 months, we also found that immune cell markers such as MHC-II and PD-L1 identify distinct EV subsets. We predict that the co-receptors and miRNA that are expressed on or contained as cargo of MHC-II EV subsets will correlate with immune responses- of the cells or the organism that produced those EVs. We have validated PD-L1 detection on cell line-derived EVs and are beginning to study detection of PD-L1 on biofluid-derived EVs. We are working with James Gulley and Tim Greten to determine whether circulating PD-L1 levels on tumor-derived EVs or antigen presenting cell-derived EVs correlate with tumor biopsy levels of PD-L1 and responses to PD-L1/PD-1-directed therapies. Similarly, we are working now with members of the Senior Prostate Group to determine whether tumor-derived EVs with PSMA, EpCAM, and CD147 correlate with prostate cancer disease burden, prognosis, and responses to treatment.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Investigator-Initiated Intramural Research Projects (ZIA)
Project #
1ZIABC011502-04
Application #
9343961
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
4
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Basic Sciences
Department
Type
DUNS #
City
State
Country
Zip Code
Wiklander, Oscar P B; Bostancioglu, R Beklem; Welsh, Joshua A et al. (2018) Systematic Methodological Evaluation of a Multiplex Bead-Based Flow Cytometry Assay for Detection of Extracellular Vesicle Surface Signatures. Front Immunol 9:1326
Morales-Kastresana, Aizea; Jones, Jennifer C (2017) Flow Cytometric Analysis of Extracellular Vesicles. Methods Mol Biol 1545:215-225
Musich, Thomas; Jones, Jennifer C; Keele, Brandon F et al. (2017) Flow virometric sorting and analysis of HIV quasispecies from plasma. JCI Insight 2:e90626
Nolan, John P; Jones, Jennifer C (2017) Detection of platelet vesicles by flow cytometry. Platelets 28:256-262
Datta, Amrita; Kim, Hogyoung; Lal, Madhu et al. (2017) Manumycin A suppresses exosome biogenesis and secretion via targeted inhibition of Ras/Raf/ERK1/2 signaling and hnRNP H1 in castration-resistant prostate cancer cells. Cancer Lett 408:73-81
Morales-Kastresana, Aizea; Telford, Bill; Musich, Thomas A et al. (2017) Labeling Extracellular Vesicles for Nanoscale Flow Cytometry. Sci Rep 7:1878
Watson, Dionysios C; Bayik, Defne; Srivatsan, Avinash et al. (2016) Efficient production and enhanced tumor delivery of engineered extracellular vesicles. Biomaterials 105:195-205
Danielson, Kirsty M; Estanislau, Jessica; Tigges, John et al. (2016) Diurnal Variations of Circulating Extracellular Vesicles Measured by Nano Flow Cytometry. PLoS One 11:e0144678